Unilever looks set to beat out Unilever in the bidding war for GlaxoSmithKline’s Western nutrition business. The acquisition would bring less than $4bn to Nestle but would strengthen the company’s position in Indian markets, which are currently showing faster growth than Western markets. Horlicks , one of Nestle leading products, dominates India ’s nutritional drinks market, which could see a slowdown in growth. Unilever has emerged as the leading bidder in a tight contest for GlaxoSmithKline's Indian Horlicks nutrition business, three people familiar with the situation told Reuters on Wednesday. Horlicks ’ growth has slowed from 15% to 4% between 2013 and 2017 .
Unilever looks set to beat out Unilever in the bidding war for GlaxoSmithKline’s Western nutrition business. The acquisition would bring less than $4bn to Nestle but would strengthen the company’s position in Indian markets, which are currently showing faster growth than Western markets. Horlicks , one of Nestle leading products, dominates India ’s nutritional drinks market, which could see a slowdown in growth. Horlicks ’ growth has slowed from 15% to 4% between 2013 and 2017 .